A novel CDK4/6 inhibitor, palbociclibFAN Li-ping, JIAO Yuan-yuan, GUO Zi-han, ZHANG Yan-hua2161-2163,2202
Droxidopa, a new drug for the treatment of neurogenic orthostatic hypotensionZHANG Zhi-ye, WANG Li2164-2166,2226
Establishment and test of an index system for evaluation of maturity of generic drug manufacturers in meeting WHO prequalification standardsHUANG Bao-bin, WU Zhi-ang, XU Ming-zhe, BAI Dong-ting, WU Chun-fu2167-2174
Comparison of implementation contents in the new revised Chinese GMP in 2010 and foreign typical GMPsYAN Jian-zhou, LI Ling, SHAO Rong2179-2182
Pharmacoeconomic evaluation guidelines of Asian countries (or regions) and its implications for ChinaHE Xu, ZHANG Fang2183-2187,2250
Operational mode of the Expert Committee on Clinical Trial in medical institutionsLI Bo, GAO Rui, LI Rui, LU Fang, ZI Ming-jie, LI Qing-na, TANG Xu-dong2188-2190,2196
Uncertainty evaluation in determination of dihydralazine in human plasma by HPLC-MS/MS安胜男, 谢潘潘, 齐文渊, 李博, 严蓓, 李扬, 胡欣, 史爱欣2191-2196
Application of metabonomics in the study of efficacy material base and mechanism of traditional Chinese medicine in the treatment of coronary heart diseaseMU Fei, DUAN Jia-lin, WEN Ai-dong, XI Miao-miao2197-2202